- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Elaine Siegfried Addresses Patient-Centered Therapeutic Management for Atopic Dermatitis
Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, discusses therapeutic management considerations for dermatologists in consulting with diverse patients with atopic dermatitis.
Shared decision-making is important to ensure patients with atopic dermatitis (AD) know how to use treatments properly and have an understanding of the associated side effects, said Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center.
Transcript
What considerations should be top of mind for dermatologists managing the care of diverse patients with AD, both in the pediatric and adult setting?
I think it's really important to pay attention to shared decision-making for treatments. Patients have to understand, first and foremost, how to use treatment, and then they also have to get access to that treatment. So, out-of-pocket costs play a big role and just being able to use the medications.
Now, when we talk about more aggressive systemic treatment, the side effect profile has to be explained in great detail, and people have to be understanding of that. And then for the biologic treatments, those are subcutaneous injections, so people have to be willing to do that as well. Although, I find that to be probably the least problematic of all the considerations.
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
October 24th 2024The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
